Characterization of a novel complex BRAF mutation in a follicular variant papillary thyroid carcinoma

European Journal of Endocrinology

Volumn 159, Issue 1, 2008, Pages 77-80

  Barzon, Luisa ^a   Masi, Giulia ^b   Boschin, Isabella Merante ^a,b   Lavezzo, Enrico ^a   Pacenti, Monia ^a   Ide, Eric Casal ^a,b   Toniato, Antonio ^a,b   Toppo, Stefano ^a   Palù, Giorgio ^a   Pelizzo, Maria Rosa ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; B RAF KINASE; BRAF PROTEIN, HUMAN;

ADULT; AMINO ACID SUBSTITUTION; ANAMNESIS; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; ENZYME ACTIVITY; FEMALE; GENE INTERACTION; GENE MUTATION; HUMAN; HUMAN TISSUE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; THYROID CARCINOMA; THYROIDECTOMY; THYROIDITIS; AMINO ACID SEQUENCE; CHEMISTRY; EXON; GENETICS; MIDDLE AGED; MUTATION; PROTEIN SECONDARY STRUCTURE; THYROID FOLLICULAR CARCINOMA; THYROID TUMOR;

AMINO ACID SEQUENCE; CARCINOMA, PAPILLARY, FOLLICULAR; EXONS; FEMALE; HUMANS; MIDDLE AGED; MUTATION; PROTEIN STRUCTURE, SECONDARY; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS;

EID: 47049116395     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-08-0239     Document Type: Article

References (13)

1. Davies H, Bigneil GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR & Futreal PA. Mutations of the BRAF gene in human cancer. Nature 2002 417 949-954.
2. Xing M. BRAF mutation in papillary thyroid cancer: pathogenetic role, molecular bases, and clinical implications. Endocrine Reviews 2007 28 742-762.
3. Wan PTC, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Cancer Genome Project, Jones CM, Marshall CJ, Springer CJ, Barford D & Marais R. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 2004 116 855-867.
4. Trovisco V, Vieira de Castro I, Soares P, Maximo V, Silva P, Magalhaes J, Abrosimov A, Guiu XM & Sobrinho-Simoes M. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. Journal of Pathology 2004 202 247-251.
5. Oler G, Ebina KN, Michaluart P Jr, Kimura ET & Cerutti J. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis. Clinical Endocrinology 2005 62 509-511.
6. Moretti S, Macchiarulo A, De Falco V, Avenia N, Barbi F, Carta C, Cavaliere A, Melilio RM, Passeri L, Santeusanio F, Tartaglia M, Santoro M & Puxeddu E. Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. Oncogene 2006 25 4235-4240.
7. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D & Ladenson PW. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2005 90 6373-6379.
8. Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G, Elisei R, Santoro M, Miccoli P & Basolo F. Association of BRAF V600E mutation with poor clinicopathologic outcomes in 500 consecutive cases of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2007 92 4085-4090.
9. de Bakker PI, DePristo MA, Burke DF & Blundell TL. Ab initio construction of polypeptide fragments: accuracy of loop decoy discrimination by an all-atom statistical potential and the AMBER force field with the Generalized Born solvation model. Proteins 2003 51 21-40.
10. LiVolsi VA, Albores-Saavedra J, Asa SL, Baloch ZW, Sobrinho-Simoes M, Wenig B, DeLellis RA, Cady B, Mazzaferri EL, Hay I, Fagin JA, Weber AL, Caruso P, Voutilainen PE, Fransila KO, Williams ED, Schneider AB, Nikiforov Y, Rabes HM, Aksen L, Ezzat S, Santoro M, Eng C & Harach HR. Papillary carcinoma. In Pathology and Genetics of Tumors of the Endocrine Organs - World Health Organization Classification of Tumors, pp 57-72. Eds LA DeLellis, RV Lloyd, PU Heitz & C Eng, Lyon: IARC Press, 2004.
11. Cruz F, Rubin BP, Wilson D, Town A, Schroeder A, Haley A, Bainbridge T, Heinrich MC & Corless CL. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Research 2003 63 5761-5766.
12. Zhang BH & Guan KL. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO Journal 2000 19 5429-5439.
13. Dhillon AS & Kolch W. Oncogenic B-Raf mutations: crystal clear at last. Cancer Cell 2004 5 303-304.